Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$2.5M
1 round on record
Latest round
$2.5M
Seed · Sep 2022 · 4 yr ago
Backers
1
Occident
The money's age
Long since its last round
48 months since the last round · not hiring
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 27, 2025 Certified Avelo Successfully Completes ISO 13485 Surveillance Audit · avelolife.com Dec 19, 2024 Certified Avelo Achieves ISO 13485:2016 Certification for its Quality Management System · avelolife.com Oct 6, 2022 Board appointment Avelo Appoints Highly Experienced Board of Directors · avelolife.com Sep 20, 2022 Raised a round Seed $2.5M
Funding rounds
RoundDateAmountInvestorsSource
Seed Sep 2022 $2.5M — avelolife.com
Registers and programsofficial lists and records that name the company
Legal entity Avelo Inc. its site
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
BiotiaVenture round $9M · this month
Biotia is advancing infectious disease diagnostics for patients managing challenging infections. Learn more about our work.
Our Vision We work to help voiceless people regain their own, natural-sounding voice. Our non-invasive silent speech technology will be a…
Llusern Scientific is a UK diagnostics company developing treatment-directing diagnostics that bring rapid molecular testing closer to the…
Savics offers digital solutions for health actors to improve their data management, disease diagnostics and GeneXpert connectivity.
T cell Based Immunotherapies for Cancer and Chronic Infectious Diseases.
Discover P95 full-service CRO clinical trial solutions. Experts in epidemiology and real-world evidence for vaccines and infectious…

Overview

Avelo’s mission is to save lives by bringing fast and actionable infectious disease diagnostics closer to the patient. Our solution is a non-invasive, easy-to-use breath sampling kit. It works with existing molecular tests to transform tuberculosis and pneumonia diagnostics.

News

News Yahoo News UK 12 days ago
Avelo Airlines Expands McKinney Operations With Third Aircraft and Four New Nonstop Routes
Avelo Airlines adds a third Boeing 737 at McKinney National Airport, launching nonstop service to four new destinations across the country.
Read more
Report
News thepointsguy 14 days ago
Avelo expands to 10 routes at Dallas's new McKinney Airport - The Points Guy
Avelo Airlines is expanding its footprint to 10 routes and three planes at the new McKinney National Airport.
Read more
Report
News Yahoo Travel 15 days ago
Avelo Adds Denver, Atlanta, New Orleans, Nashville Flights From McKinney
Avelo Airlines expands service from McKinney National Airport with new nonstop flights to Atlanta, Denver, Nashville, and New Orleans.
Read more
Report
News Aviacionline 16 days ago
Avelo Airlines doubles down on McKinney with four new routes and a third 737-800 ahead of base launch
The Texas low-cost carrier will grow its DTX network to nine destinations and base three Boeing 737-800s at the new commercial airport north of Dallas.
Read more
Report
Report
Blog 6 months ago
AveloMask Pneumonia Data Presented at ESCMID Global 2026 in Munich
April 29, 2026. Avelo AG is pleased to share that Prof. Dr. Michael Osthoff from University Hospital Basel presented real-world clinical results for AveloMask at ESCMID Global 2026 in Munich, one of the world's leading conferences in clinical microbiology
Read more
Report
Blog 7 months ago
Respiratory Viruses from Breath Samples: Virologists from Frankfurt University established AveloMask Workflow with QIAsymphony, ELITe InGenius and RespiFinder 2SMART panel
March 24, 2026. Avelo is pleased to announce new research results presented at the Annual Meeting of the German Society for Virology (GfV). The study, conducted by the Institute of Medical Virology at Goethe University Frankfurt (Ciesek group), establishe
Read more
Report
Blog 8 months ago
"No Sputum, No Problem": AveloMask Cystic Fibrosis Study Presented at DZIF Meeting
February 25, 2026. Avelo AG is pleased to announce that results from a clinical study evaluating the AveloMask Kit for detection of Pseudomonas aeruginosa in adults with Cystic Fibrosis (CF) were presented at the DZIF Annual Meeting in Bonn by researchers
Read more
Report
Show more news

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1

Financials

Total raised
$2.5M
Latest round
Seed
Funding rounds
1
Funding rounds
Round Announced Amount
Seed 2022 $2.5M Details